US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 112.690
  • +0.590+0.53%
Close Aug 23 16:00 ET
  • 112.690
  • 0.0000.00%
Post 20:02 ET
196.07BMarket Cap35.55P/E (TTM)

Abbott Laboratories Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
62.93%1.96B
-10.32%1.03B
-24.21%7.26B
30.61%3.04B
-32.48%1.88B
-50.08%1.2B
-44.65%1.14B
-9.04%9.58B
-24.16%2.33B
2.92%2.78B
Net income from continuing operations
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
-31.67%1.44B
Operating gains losses
----
----
-41.40%126M
----
----
----
----
290.91%215M
----
----
Depreciation and amortization
0.63%805M
-0.12%805M
-0.73%3.24B
0.74%813M
1.10%824M
-2.68%800M
-2.07%806M
-7.66%3.27B
-8.61%807M
-3.78%815M
Other non cash items
121.21%140M
30.48%-748M
----
----
-352.11%-179M
-817.39%-660M
-424.88%-1.08B
----
----
291.89%71M
Change In working capital
3.60%-428M
-201.61%-561M
-62.94%-2.48B
-1,436.84%-1.52B
-195.54%-321M
33.13%-444M
85.75%-186M
-97.02%-1.52B
207.55%114M
204.02%336M
-Change in receivables
-65.82%-325M
-164.81%-151M
-423.53%-356M
-80.06%68M
-186.98%-461M
-4.26%-196M
131.03%233M
82.25%-68M
280.42%341M
234.52%530M
-Change in inventory
58.47%-103M
2.15%-410M
83.58%-232M
256.08%295M
172.16%140M
47.90%-248M
24.37%-419M
-209.87%-1.41B
-1,360.00%-189M
-373.24%-194M
-Change in prepaid assets
----
----
-622.67%-542M
----
----
----
----
75.96%-75M
----
----
-Change in payables and accrued expense
----
----
-280.95%-760M
----
----
----
----
-67.39%420M
----
----
-Change in other working capital
----
----
-52.74%-585M
----
----
----
----
57.82%-383M
----
----
Cash from discontinued investing activities
Operating cash flow
62.93%1.96B
-10.32%1.03B
-24.21%7.26B
30.61%3.04B
-32.48%1.88B
-50.08%1.2B
-44.65%1.14B
-9.04%9.58B
-24.16%2.33B
2.92%2.78B
Investing cash flow
Cash flow from continuing investing activities
62.65%-453M
8.01%-425M
-80.06%-3.13B
-30.38%-824M
-30.99%-634M
-359.47%-1.21B
-28.33%-462M
13.35%-1.74B
5.81%-632M
25.65%-484M
Net PPE purchase and sale
-5.13%-533M
-4.74%-398M
-23.92%-2.2B
-23.77%-755M
-19.91%-560M
-33.77%-507M
-18.38%-380M
5.73%-1.78B
0.65%-610M
-1.30%-467M
Net business purchase and sale
----
----
-1,843.75%-837M
--0
---51M
----
----
190.57%48M
--0
--0
Net investment purchase and sale
-2.53%77M
67.44%-28M
-251.52%-116M
-136.67%-71M
-80.95%-38M
33.90%79M
-109.76%-86M
65.63%-33M
56.52%-30M
80.56%-21M
Net other investing changes
100.00%2M
-75.00%1M
0.00%22M
-75.00%2M
275.00%15M
-87.50%1M
100.00%4M
-15.38%22M
-33.33%8M
0.00%4M
Cash from discontinued investing activities
Investing cash flow
62.65%-453M
8.01%-425M
-80.06%-3.13B
-30.38%-824M
-30.99%-634M
-359.47%-1.21B
-28.33%-462M
13.35%-1.74B
5.81%-632M
25.65%-484M
Financing cash flow
Cash flow from continuing financing activities
38.63%-791M
16.60%-1.18B
7.14%-7.09B
-40.84%-2.05B
-51.65%-2.34B
-58.55%-1.29B
63.12%-1.41B
-38.99%-7.64B
22.75%-1.46B
-12.06%-1.54B
Net issuance payments of debt
1,233.33%160M
-202.38%-127M
-254.08%-2.48B
-9,490.00%-939M
-6,375.00%-1.51B
20.00%12M
94.35%-42M
-181.85%-699M
105.10%10M
135.82%24M
Net common stock issuance
99.30%-3M
58.15%-226M
67.67%-1.23B
62.19%-259M
99.75%-2M
-8,420.00%-426M
76.59%-540M
-65.07%-3.8B
29.67%-685M
-37.82%-798M
Cash dividends paid
-7.98%-961M
-7.53%-957M
-7.46%-3.56B
-7.90%-888M
-7.51%-888M
-7.49%-890M
-6.97%-890M
-3.34%-3.31B
-3.13%-823M
-3.12%-826M
Proceeds from stock option exercised by employees
-13.33%13M
116.13%134M
0.00%167M
-17.07%34M
-1.75%56M
50.00%15M
5.08%62M
-34.51%167M
-50.00%41M
-18.57%57M
Cash from discontinued financing activities
Financing cash flow
38.63%-791M
16.60%-1.18B
7.14%-7.09B
-40.84%-2.05B
-51.65%-2.34B
-58.55%-1.29B
63.12%-1.41B
-38.99%-7.64B
22.75%-1.46B
-12.06%-1.54B
Net cash flow
Beginning cash position
-31.40%6.28B
-30.22%6.9B
0.85%9.88B
-30.07%6.71B
-12.33%7.84B
19.36%9.16B
0.85%9.88B
43.30%9.8B
3.14%9.59B
3.22%8.94B
Current changes in cash
155.12%716M
20.99%-576M
-1,545.37%-2.96B
-31.65%162M
-245.68%-1.1B
-197.45%-1.3B
65.58%-729M
-93.24%205M
-53.53%237M
11.89%753M
Effect of exchange rate changes
51.85%-13M
-550.00%-36M
81.15%-23M
-50.98%25M
69.79%-29M
61.97%-27M
233.33%8M
-74.29%-122M
492.31%51M
-231.03%-96M
End cash Position
-10.82%6.99B
-31.40%6.28B
-30.22%6.9B
-30.22%6.9B
-30.07%6.71B
-12.33%7.84B
19.36%9.16B
0.85%9.88B
0.85%9.88B
3.14%9.59B
Free cash flow
105.03%1.43B
-17.82%627M
-35.17%5.06B
33.04%2.28B
-43.06%1.32B
-65.73%696M
-56.25%763M
-9.76%7.8B
-30.04%1.72B
3.26%2.31B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 62.93%1.96B-10.32%1.03B-24.21%7.26B30.61%3.04B-32.48%1.88B-50.08%1.2B-44.65%1.14B-9.04%9.58B-24.16%2.33B2.92%2.78B
Net income from continuing operations -5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B-31.67%1.44B
Operating gains losses ---------41.40%126M----------------290.91%215M--------
Depreciation and amortization 0.63%805M-0.12%805M-0.73%3.24B0.74%813M1.10%824M-2.68%800M-2.07%806M-7.66%3.27B-8.61%807M-3.78%815M
Other non cash items 121.21%140M30.48%-748M---------352.11%-179M-817.39%-660M-424.88%-1.08B--------291.89%71M
Change In working capital 3.60%-428M-201.61%-561M-62.94%-2.48B-1,436.84%-1.52B-195.54%-321M33.13%-444M85.75%-186M-97.02%-1.52B207.55%114M204.02%336M
-Change in receivables -65.82%-325M-164.81%-151M-423.53%-356M-80.06%68M-186.98%-461M-4.26%-196M131.03%233M82.25%-68M280.42%341M234.52%530M
-Change in inventory 58.47%-103M2.15%-410M83.58%-232M256.08%295M172.16%140M47.90%-248M24.37%-419M-209.87%-1.41B-1,360.00%-189M-373.24%-194M
-Change in prepaid assets ---------622.67%-542M----------------75.96%-75M--------
-Change in payables and accrued expense ---------280.95%-760M-----------------67.39%420M--------
-Change in other working capital ---------52.74%-585M----------------57.82%-383M--------
Cash from discontinued investing activities
Operating cash flow 62.93%1.96B-10.32%1.03B-24.21%7.26B30.61%3.04B-32.48%1.88B-50.08%1.2B-44.65%1.14B-9.04%9.58B-24.16%2.33B2.92%2.78B
Investing cash flow
Cash flow from continuing investing activities 62.65%-453M8.01%-425M-80.06%-3.13B-30.38%-824M-30.99%-634M-359.47%-1.21B-28.33%-462M13.35%-1.74B5.81%-632M25.65%-484M
Net PPE purchase and sale -5.13%-533M-4.74%-398M-23.92%-2.2B-23.77%-755M-19.91%-560M-33.77%-507M-18.38%-380M5.73%-1.78B0.65%-610M-1.30%-467M
Net business purchase and sale ---------1,843.75%-837M--0---51M--------190.57%48M--0--0
Net investment purchase and sale -2.53%77M67.44%-28M-251.52%-116M-136.67%-71M-80.95%-38M33.90%79M-109.76%-86M65.63%-33M56.52%-30M80.56%-21M
Net other investing changes 100.00%2M-75.00%1M0.00%22M-75.00%2M275.00%15M-87.50%1M100.00%4M-15.38%22M-33.33%8M0.00%4M
Cash from discontinued investing activities
Investing cash flow 62.65%-453M8.01%-425M-80.06%-3.13B-30.38%-824M-30.99%-634M-359.47%-1.21B-28.33%-462M13.35%-1.74B5.81%-632M25.65%-484M
Financing cash flow
Cash flow from continuing financing activities 38.63%-791M16.60%-1.18B7.14%-7.09B-40.84%-2.05B-51.65%-2.34B-58.55%-1.29B63.12%-1.41B-38.99%-7.64B22.75%-1.46B-12.06%-1.54B
Net issuance payments of debt 1,233.33%160M-202.38%-127M-254.08%-2.48B-9,490.00%-939M-6,375.00%-1.51B20.00%12M94.35%-42M-181.85%-699M105.10%10M135.82%24M
Net common stock issuance 99.30%-3M58.15%-226M67.67%-1.23B62.19%-259M99.75%-2M-8,420.00%-426M76.59%-540M-65.07%-3.8B29.67%-685M-37.82%-798M
Cash dividends paid -7.98%-961M-7.53%-957M-7.46%-3.56B-7.90%-888M-7.51%-888M-7.49%-890M-6.97%-890M-3.34%-3.31B-3.13%-823M-3.12%-826M
Proceeds from stock option exercised by employees -13.33%13M116.13%134M0.00%167M-17.07%34M-1.75%56M50.00%15M5.08%62M-34.51%167M-50.00%41M-18.57%57M
Cash from discontinued financing activities
Financing cash flow 38.63%-791M16.60%-1.18B7.14%-7.09B-40.84%-2.05B-51.65%-2.34B-58.55%-1.29B63.12%-1.41B-38.99%-7.64B22.75%-1.46B-12.06%-1.54B
Net cash flow
Beginning cash position -31.40%6.28B-30.22%6.9B0.85%9.88B-30.07%6.71B-12.33%7.84B19.36%9.16B0.85%9.88B43.30%9.8B3.14%9.59B3.22%8.94B
Current changes in cash 155.12%716M20.99%-576M-1,545.37%-2.96B-31.65%162M-245.68%-1.1B-197.45%-1.3B65.58%-729M-93.24%205M-53.53%237M11.89%753M
Effect of exchange rate changes 51.85%-13M-550.00%-36M81.15%-23M-50.98%25M69.79%-29M61.97%-27M233.33%8M-74.29%-122M492.31%51M-231.03%-96M
End cash Position -10.82%6.99B-31.40%6.28B-30.22%6.9B-30.22%6.9B-30.07%6.71B-12.33%7.84B19.36%9.16B0.85%9.88B0.85%9.88B3.14%9.59B
Free cash flow 105.03%1.43B-17.82%627M-35.17%5.06B33.04%2.28B-43.06%1.32B-65.73%696M-56.25%763M-9.76%7.8B-30.04%1.72B3.26%2.31B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg